Information  X 
Enter a valid email address

Tesco PLC (TSCO)

  Print   

Wednesday 26 January, 2022

Tesco PLC

Transaction in Own Shares

RNS Number : 7648Z
Tesco PLC
26 January 2022
 

 

Tesco PLC

Transaction in own shares

Tesco PLC (the "Company") announces that on 26 January 2022 it has purchased, in accordance with the authority granted by shareholders at the 2021 Annual General Meeting of the Company, the following number of ordinary shares of 6 1/3 pence pursuant to its up to 500 million share buyback programme, the details of which were announced on 18 October 2021.

The purchased shares will be cancelled.

Description of shares:

Tesco PLC - ordinary shares of 6 1/3 pence

Date of transaction

26 January 2022

Number of Shares purchased:

433,352

Average price paid per Share (pence):

293.03p

Highest price paid per Share (pence):

294.00p

Lowest price paid per Share (pence):

290.40p

Broker:

Citigroup Global Markets Limited

Following the purchase of these shares, the remaining number of ordinary shares in issue will be 7,649,485,480. The Company does not hold any ordinary shares in Treasury. 

The figure of 7,649,485,480 may be used by shareholders (and others with notification obligations) as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure and Transparency Rules.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it applies in the UK (the Market Abuse Regulation), a full breakdown of the individual purchases is attached to this announcement.

Further enquiries:

Investor relations:   Chris Griffith  01707 940 900

Media:  Christine Heffernan 0330 678 0639

Tesco PLC's LEI number is: 2138002P5RNKC5W2JZ46

  http://www.rns-pdf.londonstockexchange.com/rns/7648Z_1-2022-1-26.pdf

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFLFITLFIRFIF

a d v e r t i s e m e n t